RemedyRepack Inc. recalls Cefixime 400 mg capsule, packaged in a) 2-count bottle (NDC 70518-2749-02), b) 2-count blister pack (NDC 70518-2749-03),
Recalled January 12, 2022 · FDA recall D-0360-2022 · RemedyRepack
Hazard
Failed Impurities/Degradation Specifications · FDA Class II
Units
a) 716 bottles/ 1432 capsules b) 223 blister packs/ 466 capsules
Sold at
Product was distributed to two direct accounts in MI and PA.
Description
Failed Impurities/Degradation Specifications
Product
Cefixime 400 mg capsule, packaged in a) 2-count bottle (NDC 70518-2749-02), b) 2-count blister pack (NDC 70518-2749-03), Rx only, MFG: Ascend Labs, LLC, Montvale, NJ 07645
Manufacturer(s)
RemedyRepack Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →